1.​ What are the chief complaints and their evolution?

1 month PTC:
●​ Intermittent high grade febrile episodes
●​ (+) Chills
●​ (+) Rigors
●​ Productive cough with thick yellowish sputum
●​ Pleuritic chest pain of left side, worsened with deep inspiration and forceful
coughing
●​ (+) Fatigue
●​ (+) Appetite loss
●​ (+) Weight loss of 5 kg

​ 2 weeks PTC:
●​ Progressive shortness of breath

​ 10 days PTC:
●​ Oral antibiotics (Amoxicillin-Clavunate, 1 g, bid) did not resolve symptoms

​ 1 day PTC:
●​ Blood streaks in sputum

2.​ Which risk factors in history stand out?

Family History:
●​ Father, deceased, age 52 due to lung cancer
●​ Mother, alive, hypertensive
●​ No known family history of TB

​ Social and Occupational History

●​ Works as government employee, recently assigned to a mining project on
Tawi-tawi with poor ventilation and dust exposure
●​ Lives in an urban apartment
●​ Smokes 5 packyears

3.​ How does non-response to antibiotics influence your thinking?

​ Some of the reasons to consider after failure to respond to empiric antibiotic therapy
include (1) the accuracy of the initial diagnosis; (2) spectrum of antimicrobial coverage, also
consider resistant or intracellular etiologic pathogen; (3) presence of host-related or structural
complications. It is also important to reevaluate differential diagnoses or co-existing pathologies
and diseases overlaps through repeated physical examination, and additional diagnostic
workups such as imaging to detect effusion, abscess, cavitation, or malignancy, as well as
microbiologic reassessment or bronchoscopy if diagnosis remains unclear.
 4.​ What are the significant chest findings?
a.​ History
i.​ Productive cough
ii.​ Dyspnea
iii.​ Yellowish sputum
iv.​ Pleuritic Chest Pain
v.​ Blood streaked sputum (1day PTC)
b.​ Physical Examination
i.​ Asymmetric chest expansion
ii.​ Dullness to percussion (left base)
iii.​ Decreased breath sounds
5.​ Which extra-pulmonary findings are important?
a.​ Oral thrush
b.​ Palpable, non-tender cervical lympadenopathy (1-2 cm nodes)
c.​ Digital clubbing
d.​ Diffuse hyperpigmented excoriated maculopapular lesions on face
6.​ What constitutional symptoms are present or absent?
a.​ Present
i.​ Sudden onset fever
ii.​ Rigors and chills
iii.​ Cachexia
iv.​ Significant weight loss
v.​ Underweight (BMI)
b.​ Absent
i.​ Night sweats
ii.​ Palpitation
iii.​ Orthopnea

7.​ What other systems are unremarkable, and why is that important?

System Findings Why It’s Important

Cardiovascular No palpitations, orthopnea, or Rules out heart failure,

PND. Heart sounds normal, endocarditis, and pericardial
no murmurs, no JVD. diseases causes of dyspnea.
If dyspnea were cardiac, we’d
 expect edema, orthopnea, or
rales — which are absent.

Gastrointestinal No nausea, vomiting, Makes liver disease,

diarrhea, hematemesis, abdominal TB, or
melena; abdomen soft, no disseminated fungal infection
hepatosplenomegaly. with hepatosplenomegaly
less likely. Also rules out
malabsorption as cause of
weight loss.

Genitourinary No dysuria, hematuria, flank Excludes renal infection, UTI,

pain. or renal TB as sources of
fever or systemic infection.

Neurologic No headache, seizures, Rules out CNS TB,

weakness, or focal deficits. cryptococcal meningitis,
toxoplasmosis, or metastases
— important if HIV or
malignancy is suspected.

Musculoskeletal No joint pain, no swelling. Makes connective tissue

disease, reactive arthritis, or
disseminated TB with bone
involvement less likely.

Cardiorespiratory exam No wheezes, no stridor, no Suggests localized, not

(apart from left-sided generalized crackles. diffuse, lung process (so
findings) likely TB cavity or localized
effusion, not asthma or
COPD).

Skin (systemic signs) No photosensitivity or Suggested skin lesions are

vasculitic rashes (aside from infection-related, not
noted lesions). autoimmune.

8.​ Based on Hx, PE, and ROS, what is your initial working impression?
“Pulmonary tuberculosis with concomitant infection probably HIV; cannot rule out lung
malignancy”
On the basis of

Pertinent (+) Pertinent (-)

HPI HPI
●​ Dyspnea ●​ No HTN
●​ intermittent high-grade fever ●​ No DM
●​ Chills ●​ No Asthma
●​ Productive cough of thick, yellowish ●​ No previous surgery
sputum ●​ No previous TB treatment
●​ Fatigue ●​ No maintenance medication
●​ Decreased appetite ●​ No travel history
●​ Weight loss ●​ No known TB contact
●​ Hemoptysis
●​ Paternal history of Lung CA PE
●​ Smoker (5 pack years) ●​ No hypoxemia
●​ Occasional alcohol drinker ●​ No cyanosis
●​ Occupational exposure to dust with ●​ No jaundice
poor ventilation ●​ No peripheral edema
●​ No JVD
PE ●​ No thyroid enlargement
●​ Cachectic ●​ No wheezing
●​ Underweight ●​ No stridor
●​ Mildly dyspneic ●​ Decreased bowel sounds
●​ Febrile ●​ No hepatoslenomegaly
●​ Tachycardic ●​ No palpable mass on abdomen
●​ Tachypneic ●​ No calf tenderness
●​ Diffuse hyperpigmented excoriated ●​ Capillary refill <2 seconds
maculopapular lesions on face, torso, ●​ Alert
and soles ●​ Oriented 3x
●​ Oral thrush ●​ Coherent speech
●​ lymphadenopathy ●​ Cranial nerves intact
●​ Asymmetric chest expansion ●​ Motor sensory exam normal
●​ Dullness to percussion at left base ●​ Reflexes symmetric
●​ Decreased breath sounds ●​ No focal deficits
●​ Clubbing
ROS
●​ No palpitations
●​ No orthopnea
●​ No PND
●​ NO Nausea
●​ No vomiting
●​ No hematemesis
●​ No melena
●​ No dysuria
●​ No hematuria
●​ No flank pain
●​ No headache
●​ No seizure
●​ No syncope
 ●​ No joint swelling
●​ No joint pain
●​ No photosensitivity

9.​ What are at least 5 differential diagnoses?

●​ Lung malignancy
○​ Rule in:

■​ Paternal history of Lung CA

■​ Male
○​ Rule out:
■​ No wheezing
■​ No stridor
■​ No bone pain
■​ Oral thrush
■​ <40 years old

●​ Pulmonary Tuberculosis
○​ Rule in:
■​ Weight loss
■​ Hemoptysis
■​ Anorexia
■​ Cough
■​ Chest pain
■​ Fever
 ■​ Dyspnea
■​ Clubbing
■​ Lymphadenopathy
■​ Risk factor:
●​ Male
●​ From endemic country (Philippines)
●​ Smoker (5 pack-years)
●​ Low ventilation working environment (mining)
○​ Rule out
■​ No known TB contact
■​ No night sweats

●​ Community-Acquired Pneumonia
○​ Rule in
■​ Fever
■​ Chills
■​ Productive cough
■​ Dyspnea
■​ Chest pain
■​ Tachycardic
■​ Tachypneic
■​ Smoker (5 pack-years)
■​ Asymmetric chest expansion
■​ Dullness to percussion
○​ Rule out:
■​ Oral thrush
■​ Weight loss

●​ COPD (Chronic bronchitis)

○​ Rule in
■​ Productive cough
■​ Dyspnea
■​ Weight loss
■​ Cachectic
■​ Smoker (5 pack-years)
■​ Occupational exposure to dust
○​ Rule out:
■​ No wheezing
■​ No crackles
■​ No cyanosis
■​ No hypoxemia
■​ Fever
■​ Chills
 ■​ Chest pain

●​ Bronchiectasis
○​ Rule in:
■​ Dyspnea
■​ Productive cough
■​ Hemoptysis
■​ Clubbing
■​ Smoker (5 pack-years)
■​ Cachectic
○​ Rule out
■​ Weight loss
■​ Fever
■​ Chills
■​ Oral thrush
■​ No hypoxemia

10.​How do the extrapulmonary findings influence your differential diagnosis and next steps
in evaluation?
-The extrapulmonary findings that influence the differential diagnosis:
A.​ Cervical Lymphadenopathy: TB lymphadenitis or Lung Malignancy
B.​ Hyperpigmented maculopapular rashes on face, torso, palms, and soles:
Systemic illness or secondary infection
C.​ Cachexia (Muscle Wasting) and Fatigue: Systemic disease or Lung Malignancy
D.​ Nail Clubbing: TB, Brochiectasis, or Lung cancer
11.​What is the significance of hemoptysis in this patient, and how does it alter the urgency
and scope of your workup?
-​ Hemoptysis indicated involvement of lung parenchyma. This, in combination with
cachexia and nail clubbing (also the other danger signs), may warrant further
work-up for the patient to assess for possible infections, the severity of the
disease if seen in the inner parts, and the progression of the disease.
12.​Given the occupational exposure to mining dust, how would you differentiate between
infectious and non-infectious pulmonary conditions?
Onset & Course:
●​ Infectious: Usually acute or subacute; may present with fever, chills, and productive
cough.
●​ Non-infectious: Gradual, chronic progression without fever; dry cough and exertional
dyspnea predominate.
Symptoms:
●​ Infectious: Fever, purulent or blood-streaked sputum, pleuritic chest pain, weight loss.
●​ Non-infectious: Chronic dry cough, progressive dyspnea, minimal sputum, no fever.
Physical findings:
●​ Infectious: Focal crackles, bronchial breath sounds, or dullness (lobar involvement).
 ●​ Non-infectious: Diffuse fine crackles (fibrosis) or normal early findings.
Response to antibiotics:
●​ Infectious: May improve with appropriate antimicrobial therapy.
●​ Non-infectious: No improvement despite antibiotics.
Radiologic findings:
●​ Infectious: Consolidation, cavitation, or nodular infiltrates (e.g., TB).
●​ Non-infectious: Diffuse small nodules, upper lobe fibrosis, or eggshell calcifications
(silicosis).
Laboratory tests:
●​ Infectious: Positive sputum AFB, GeneXpert, or culture; elevated inflammatory markers.
●​ Non-infectious: Negative microbiologic tests; HRCT may show fibrotic or nodular
changes.

13.​What laboratory and imaging studies would you prioritize at this stage, and why?

Imaging Studies:

●​ Chest Xray
-​ First line imaging for routine respiratory and cardiovascular workup.
-​ To check for the presence of effusion, consolidation, infiltrates, or mass lesions.
●​ Electrocardiogram
-​ ​To evaluate for tachyarrhythmia or right heart strain, detection of cardiac
involvement.
●​ Abdominal Ultrasound
-​ To check for hepatic, splenic, or intra-abdominal pathology, particularly to assess
for tuberculous involvement, hepatosplenomegaly, or other causes of abdominal
tenderness and distension.

Laboratory Tests:

●​ CBC
-​ To check for leukocytosis to confirm infection, neutrophilia (bacteremia)
lymphocytosis (viremia, tuberculosis), eosinophilia (asthma, eosinophilic
pneumonia), and to evaluate for anemia.
●​ Urinalysis
-​ To assess the patient’s renal status, hydration, and presence of infection or
metabolic abnormalities.
●​ ABG
-​ To assess the patient’s oxygenation, ventilation, and acid–base status.
●​ CRP & ESR
-​ Part of the laboratory work-up to assess the degree of systemic inflammation and
to provide supportive evidence of a chronic infection such as tuberculosis.
●​ Procalcitonin
 -​ To help differentiate between a bacterial lower respiratory tract infection and
tuberculosis or non-bacterial inflammation.
●​ Sputum Gram Stain
-​ To identify possible bacterial pathogens responsible for the patient’s persistent
productive cough and to assess for superimposed bacterial infection.
●​ AFB & Gene Xpert
-​ To confirm or rule out the diagnosis of pulmonary tuberculosis, detect rifampicin
resistance.
●​ HIV Test
-​ To check for possible HIV co-infection, given the presence of oral thrush, chronic
pulmonary symptoms, weight loss, and generalized skin lesions.
●​ KOH Test
-​ Oral swab and skin scrapings to confirm the presence of fungal elements such as
candida, given the patient’s oral thrush and diffuse skin lesions.

●​ Blood Culture
-​ To check for bacteremia or sepsis, which is a possible cause of this patient’s
persistent febrile illness despite antibiotic therapy.

●​ FBS
-​ To screen for diabetes mellitus or infection-related hyperglycemia.
●​ Serum Electrolytes
-​ To evaluate for fluid and electrolyte disturbances secondary to infection,
dehydration, or renal dysfunction, and to establish a baseline prior to initiating
potentially nephrotoxic or hepatotoxic medications.
●​ Lipid Profile
-​ To assess the patient’s nutritional and metabolic status and to obtain a baseline
for cardiovascular risk evaluation prior to the initiation of long-term medications.
●​ Renal and Liver Function Tests
-​ To establish baseline organ status and evaluate for possible renal or hepatic
dysfunction, which may contribute to the patient’s systemic illness and guide safe
initiation of medical therapy.
●​ D-Dimer
-​ To rule out or rule in pulmonary embolism.
●​ Carcinoembryonic Antigen (CEA) Test
-​ To screen for possible lung malignancy, as part of the differential diagnosis.

14.​How does the family history of lung cancer shape your diagnostic reasoning in this case?
●​ The patient’s family history of lung cancer increases his predisposition to malignancy,
especially given his occupational dust exposure and chronic pulmonary symptoms. Both
genetic susceptibility and environmental risk contribute to the pathogenesis of lung
cancer.
●​ While infectious etiologies (TB) remain most likely given the presence of fever, oral
thrush, and cachexia, the family history compels the clinician to maintain a high index of
suspicion for malignancy.
●​ Further diagnostic work-up (chest CT, sputum cytology, bronchoscopy with biopsy) would
be warranted if TB workup is negative or if lesions appear nodular, irregular, or
cavitating.

15.​What psychosocial considerations should be addressed in parallel with the

medical workup?
●​ Stigma and anxiety
○​ about possible TB diagnosis
■​ Reassure him that TB and other chronic lung diseases are treatable.
■​ Maintain confidentiality
■​ Provide counseling and education about the illness to reduce fear.
■​ If available, involve a social worker or psychologist for mental support.
○​ Fear of hereditary disease (family history: lung cancer)
■​ Provide accurate information: lung cancer risk is influenced by smoking
and environmental exposure, not purely genetics.
■​ Encourage smoking cessation and regular medical screening for himself
and his family.
■​ Reinforce that early detection and treatment improve survival.
●​ Socioeconomic: mining job, lives with family
○​ Impact on family and social life
■​ Educate the family about infection control
■​ (Infection control for family) Arrange contact tracing and screening for his
wife and children.
■​ Offer family counseling to address fears and misunderstandings.
■​ Refer to the local health center for free TB evaluation and management
support if needed.
○​ Occupational and financial concerns (if na diagnosed si patient for tb)
■​ Coordinate with occupational health services to ensure safe return to
work later and proper dust control.
■​ Assist with sick leave documentation and referrals to government support
programs (e.g., PhilHealth TB-DOTS).
■​ Emphasize that rest and adherence to treatment are necessary for
recovery.
●​ Nutrition: BMI 13 suggests severe malnutrition
○​ Provide nutritional counseling and possibly supplemental feeding
○​ Encourage small frequent meals with protein and calories.
○​ Connect him with community or government nutrition programs if available.
●​ Mental health: low mood noted
○​ Screen for depression or anxiety during follow-ups.
 ○​ Provide empathy and encouragement
○​ Offer referral to a mental health professional if needed.
●​ Public health and community context
○​ If this is an infectious case (like TB), we must balance patient confidentiality with
public safety.
○​ Public health workers should be informed (with consent) for contact tracing and
infection control.
○​ His workplace (mining site) may also need environmental and medical screening
for co-workers.

16.​What is the clinical significance of digital clubbing in this patient, and which chronic
pulmonary or systemic conditions should it make you consider?
Digital clubbing is a painless, bulbous enlargement of the distal phalanges of fingers and toes,
caused by proliferation of connective tissue, particularly on the dorsal surface of the terminal
phalanges.

Mechanism (pathophysiology):

Not fully understood, but thought to involve:

Megakaryocyte and platelet-derived growth factors (like PDGF, VEGF) that bypass normal
filtration in the lungs due to vascular abnormalities or inflammation.

These factors lodge in the distal circulation → stimulate connective tissue proliferation.

Result: increased vascularity and soft tissue hypertrophy at nail beds → clubbing.

🔹 Clinical Significance in This Patient

In this 35-year-old male with:

●​ Chronic productive cough

●​ Hemoptysis
●​ Weight loss
●​ Unilateral pleural findings
●​ Cervical lymphadenopathy
●​ Oral thrush and cachexia

The presence of digital clubbing indicates a chronic, suppurative, or infiltrative pulmonary

process not just acute pneumonia.

It suggests the disease has been ongoing for weeks to months, not days, even if the patient
perceives it as “2 weeks.”
Chronic Pulmonary and Systemic Conditions Associated with Clubbing

Pulmonary Causes

1. Lung malignancy (especially non–small cell types like adenocarcinoma)

Most common cause of unilateral or marked clubbing in adults.
Relevant here: family history of lung cancer + weight loss + hemoptysis.

2. Chronic suppurative lung disease

Bronchiectasis
Lung abscess
Empyema

Suggestive here because of chronic sputum, pleuritic pain, and unilateral findings.

3. Pulmonary tuberculosis

Common in endemic areas; causes chronic infection and fibrosis.

The combination of hemoptysis, weight loss, and lymphadenopathy fits.

4. Idiopathic pulmonary fibrosis or chronic interstitial lung disease

Clubbing often early manifestation; but less likely here due to infectious presentation.

5. Cystic fibrosis (in younger patients)

Cardiovascular Causes
●​ Cyanotic congenital heart disease
●​ Infective endocarditis
●​ Aortic aneurysm or graft infection → Less likely here (no murmur, no cyanosis, normal
cardiac findings).

Gastrointestinal / Hepatic Causes

●​ Inflammatory bowel disease (ulcerative colitis, Crohn’s)
●​ Cirrhosis (especially primary biliary cholangitis) → No GI symptoms or hepatomegaly in
this patient.

Systemic Conditions
●​ HIV-associated lung disease (e.g., chronic infections, lymphoma)
 ●​ Oral thrush and generalized lymphadenopathy in this patient raise suspicion of
immunocompromise (possible HIV infection).

> Digital clubbing in this patient is a sign of a chronic, likely suppurative or infiltrative pulmonary
disease rather than an acute infection. It indicates long-standing hypoxia or chronic
inflammatory stimulation of vascular and connective tissues.
Possible associated conditions to consider:
1. Pulmonary tuberculosis
2. Bronchiectasis or lung abscess
3. Lung malignancy (esp. adenocarcinoma)
4. Chronic fungal infection (e.g., histoplasmosis)
5. HIV-related chronic pulmonary infection or malignancy

17.​How does the patient's BMI 13.0 affect both your diagnostic reasoning and your
approach to management?
Sudden and significant weight loss can be associated with physiological e.g. aging or
pathological: malignant neoplasms, chronic inflammatory or infectious diseases, metabolic
disorders or psychiatric disorders). In patients with malignant neoplasm.
Most common malignant causes of UWL are GI, hepatobiliary, hematologic, lung, breast, GU,
ovarian and prostate. 50% of patients lose body weight. ⅓ lose more than 5% of original body
weight and up to 20% of cancer deaths are caused directly by cachexia (immobitlity and/or
cardiac/respiratory failure).
GI diseases are among the most prominent causes of UWL. PUD, IBS, dysmotility syndromes,
chronic pancreatitis, celiac disease, constipation, and atrophic gastritis. Oral and dental
problems are overlooked.
Infectious diseases are well documented causes of UWL such as TB, fungal diseases,
parasites, subacute bacterial endocarditis and HIV.
Cardiovascular and pulmonary diseases cause UWL through increased metabolic demand,
decreased appetite and caloric intake.
Repeated surgeries reduce caloric intake and increased metabolic demands resulting from a
systemic inflammatory response
Uremia, connective tissue diseases, diabetes mellitus, hyperthyroidism, neurologic injuries,
isolation and depression, alcoholism also causes UWL.
ASSESSMENT
Four manifestations of UWL: 1. Anorexia, 2. Sarcopenia, 3. Cachexia, 4. Dehydration
Alternatives for direct weight measurement that are suggestive of true weight loss:
-​ A change in clothing size
-​ Corroboration of weight loss by a relative or friend
-​ Numeric estimate of weight loss provided by patient
Initial assessment:
●​ Comprehensive history
●​ Physical examination
●​ CBC
●​ Liver function tests
●​ Renal function tests
●​ C-reactive protein
●​ ESR
●​ Thyroid function test
●​ chest radiograph
●​ abdominal utz
Patients at high risk should have HIV testing. Elderly patients with weight loss should undergo
screening for dementia and [Link] all patients with a malignancy and >90% of those
with other organic diseases have at least one laboratory abnormality. In patients presenting with
substantial UWL, major organic and malignant diseases are unlikely when a baseline evaluation
is completely normal. Careful follow-up rather than additional undirected testing is advised
because the prognosis of weight loss of undetermined cause is generally favorable.
 18.​What infection control or public health measures would you consider in this case, given
the possible differential diagnoses and the patient's social/occupational exposures?
-​ Because MM presents with chronic cough, hemoptysis, weight loss, and occupational
exposure to dust/poor ventilation, tuberculosis (TB) remains a strong differential
diagnosis. Therefore, both infection control and public health measures are crucial — to
protect others, ensure early diagnosis, and break transmission.

A.​ Infection Control (Health Facility Level):

-​ Isolate the patient immediately in a well-ventilated or airborne infection isolation room
while TB is being ruled out.
-​ Implement airborne precautions: healthcare workers wear N95 masks, and the patient
wears a surgical mask during transport.
-​ Ensure good ventilation, limit exposure, and fast-track diagnostic tests (AFB smear,
GeneXpert, chest X-ray).
-​ Educate the patient on cough etiquette and hand hygiene.​

B.​ Public Health Measures (Community Level):

-​ Report the suspected TB case to the local health authorities for registration and
surveillance.
-​ Conduct contact tracing and screening for household and workplace contacts.
-​ Provide health education on TB prevention, treatment adherence, and stigma reduction.
-​ Implement occupational health interventions—improve ventilation and dust control at the
mining site.

SARIUL
1.​ Which findings are consistent with a subacute to chronic pulmonary process?

Findings in the Case Suggesting a subacute–chronic pulmonary process

1. Duration and Course

●​ Progressive dyspnea for 2 weeks and symptoms persisting >10 days despite antibiotics
→ not typical of acute pneumonia.
●​ Weight loss (5 kg in one month) → constitutional symptom of chronic infection or
malignancy.
●​ Fatigue and decreased appetite → constitutional features of a chronic disease process.
2. Physical Examination
●​ Cachexia (BMI 13) → chronic catabolic state.
●​ Digital clubbing → marker of long-standing pulmonary disease (e.g., TB, bronchiectasis,
malignancy).
 ●​ Cervical lymphadenopathy → suggests chronic granulomatous or neoplastic disease.
●​ Oral thrush → indicates possible chronic immunosuppression (HIV-related TB possible).
3. Laboratory Findings

●​ Anemia of chronic disease (Hgb 9.8 g/dL).

○​
●​ Elevated ESR (78 mm/hr) and CRP (48 mg/L) → ongoing chronic inflammation.
○​
●​ Pleural fluid:
-Protein >3.0 g/dL, LDH 500 IU/L → exudative effusion (Light’s criteria) typical of chronic
infection like tuberculous pleuritis.
-Lymphocyte predominance (70%) → chronic process (TB, lymphoma, or malignancy).
-Sputum AFB positive → confirms Mycobacterium tuberculosis infection, a chronic
granulomatous disease.

4. Imaging Findings
●​ Chest X-ray: left-sided pleural effusion with likely parenchymal opacity (blunting of
costophrenic angle).
●​ → consistent with tuberculous pleural effusion, a subacute-to-chronic process.

2.​ What is the significance of the patient’s weight loss and night sweats in relation to
respiratory symptoms?
The patient’s progressive weight loss is a significant constitutional symptom that points toward a
chronic systemic illness rather than an acute respiratory infection. In chronic pulmonary
diseases, particularly tuberculosis, weight loss results from the prolonged inflammatory
response mediated by cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukins
(IL-1, IL-6). These cytokines suppress appetite and increase metabolic demand, leading to
catabolism and cachexia, as reflected in this patient’s body mass index (BMI) of 13.0.
Although night sweats are classically associated with pulmonary tuberculosis, their absence
does not rule out the disease. Night sweats, when present, are due to the cyclical release of
pyrogenic cytokines that cause low-grade fever and diaphoresis during defervescence. The
combination of chronic cough, weight loss, and pleural effusion in this patient still strongly
indicates a subacute to chronic pulmonary infection, with tuberculosis being the most likely
etiology. Therefore, weight loss in this context signifies systemic involvement and chronicity,
supporting the suspicion of a chronic granulomatous disease rather than an acute bacterial
pneumonia.

3. How does the presence of hemoptysis influence your differential diagnosis?

The presence of hemoptysis, or blood-streaked sputum, adds an important dimension to the

clinical picture. Hemoptysis suggests parenchymal or airway involvement with erosion of small
blood vessels due to inflammation, necrosis, or neoplastic invasion. In a patient with a chronic
productive cough, constitutional symptoms, and a positive sputum AFB smear, tuberculosis
becomes the leading diagnosis. Hemoptysis in TB commonly results from caseating necrosis of
lung parenchyma, rupture of small bronchial vessels, or erosion of a Rasmussen’s aneurysm
within a cavitary lesion.
However, hemoptysis also broadens the differential diagnosis to include other chronic
pulmonary conditions. Bronchiectasis can present with recurrent hemoptysis due to dilated,
inflamed airways, often following previous infections such as TB. Lung malignancy, especially in
a smoker with a family history of lung cancer, must also be considered. In this case, however,
the presence of lymphocytic exudative effusion, positive AFB, and relatively young age favor
tuberculous etiology over malignancy. Thus, hemoptysis here signifies active disease and
parenchymal involvement, consistent with pulmonary tuberculosis with pleural extension.

4. Are there any features that suggest extrapulmonary involvement?

Several findings in this case point toward possible extrapulmonary involvement. The palpable,
non-tender cervical lymphadenopathy suggests tuberculous lymphadenitis, one of the most
common forms of extrapulmonary TB. Oral thrush raises concern for underlying
immunosuppression, such as HIV co-infection, which predisposes to both pulmonary and
extrapulmonary tuberculosis. Additionally, the patient’s slight LUQ tenderness and mild
abdominal distension could indicate early splenic or peritoneal involvement, both recognized
sites of dissemination in TB.
The markedly elevated ESR (78 mm/hr) and CRP (48 mg/L) reflect a systemic inflammatory
response, supporting the likelihood of disseminated disease. The presence of constitutional
symptoms—weight loss, fever, fatigue—also emphasizes systemic spread beyond the lungs.
Therefore, while pulmonary tuberculosis is the primary process, the clinical and laboratory
findings are compatible with concomitant extrapulmonary tuberculosis, particularly involving
lymphatic and possibly abdominal structures.
PABES​
INFLAMMATORY MARKERS
1.​ What do the CRP, ESR, and ferritin levels suggest about the disease chronicity and
activity?
-Markedly elevated CRP (48 mg/L) and ESR (78 mm/hr) indicate active and chronic
inflammation. Elevated ferritin (420 ng/mL) supports ongoing inflammatory activity,
typical of chronic infection like TB rather than a purely acute bacterial process.
2.​ How do these markers help differentiate between infectious and noninfectious causes of
pleural effusion?
-The high CRP and ESR favor an infectious (exudative) etiology (like TB or pneumonia)
over noninfectious (transudative) causes like heart failure or malignancy. In TB, both
markers are elevated but persist longer, distinguishing it from short-lived bacterial
infections.
3.​ What does the TPAG tell us about the nature of the effusion?
-Serum TPAG (9.1 g/dL) and pleural protein (>3.0 g/dL) indicate exudative effusion due
to increased capillary permeability from infection/inflammation rather than hydrostatic
causes. This pattern is typical of tuberculous pleuritis.
4.​ Could the elevated ferritin be due to infection, inflammation, or another process?
-In this case, infection and inflammation are the primary causes. Ferritin is an
acute-phase reactant, rising in response to macrophage activation during TB. Less likely
causes (iron overload, malignancy, liver disease) are not supported by other lab findings.
Campos
Clinical Decision-Making
1.​ Would you initiate treatment now, or wait for additional diagnostics? Justify your
approach.

Category Result Interpretation

CBC Mild anemia, ↑WBC with Suggests chronic infection or
lymphocyte predominance inflammation (consistent with TB)

Albumin Low Indicates malnutrition and chronic

disease effect

Pleural fluid Exudative (↑protein, ↑LDH), Classic for tuberculous pleuritis or

lymphocyte-predominant malignancy

AFB sputum Positive Confirms Mycobacterium

tuberculosis infection (active
pulmonary TB)

Chest X-ray / CT (as described) Left-sided effusion with infiltrates / Consistent with TB with pleural
possible consolidation involvement, but malignancy still
possible

BMI 13 Severe malnutrition (increases TB

susceptibility and poor healing)

●​ Initiate treatment now given the strong evidence

○​ AFB-positive sputum = definitive evidence of TB.
○​ Pleural fluid pattern (lymphocytic, exudative) reinforces TB rather than
pneumonia.
○​ Systemic findings (weight loss, fever, night sweats, anorexia, low albumin)
align with chronic TB.
●​ Initial anti-TB regimen (typical first-line; follow national guidelines):
■​ Intensive phase (2 months): Isoniazid (INH) + Rifampicin (RIF) +
Pyrazinamide (PZA) + Ethambutol (EMB) — daily dosing.
■​ Continuation phase (4 months): INH + RIF daily or as per DOTS
schedule.
■​ Adjust dosing for weight; monitor for drug interactions and
toxicity.
●​ Nutritional Plan
○​ Low albumin, low BMI = malnutrition → worsens TB prognosis, delays
recovery.
■​ Plan high-protein diet, vitamin/mineral supplementation, and
nutrition team referral.
2.​ What complications should you anticipate based on the diagnostic profile?
A.​ Respiratory Complications
○​ Massive Hemoptysis - Chronic TB destroys lung parenchyma and
erodes blood vessels (especially Rasmussen aneurysm from cavity wall).
○​ Bronchiectasis - Recurrent TB inflammation causes permanent dilation
and fibrosis of bronchi.
 ○​ Fibrothorax / Pleural Thickening - Pleural effusion in TB can lead to
fibrosis and scarring of the pleural space after healing.
○​ Chronic Respiratory Failure - Extensive parenchymal destruction and
pleural fibrosis reduce lung compliance and gas exchange.
○​ Coexisting Malignancy (Lung Cancer) - Family history + chronic lung
injury from TB and inflammation increase cancer risk.
■​ Cannot rule out lung cancer
B.​ Infectious Complications
○​ Miliary Tuberculosis - Hematogenous dissemination of Mycobacterium
tuberculosis from lungs to other organs.
○​ Tuberculous Meningitis or Pericarditis - Spread from primary lung
lesion to meninges or pericardium.
○​ Drug-Resistant TB (MDR-TB or XDR-TB) - Non-adherence or prior
incomplete treatment courses; also possible if patient acquired infection
from resistant strain.
C.​ Hematologic and Nutritional Complications
○​ Anemia of Chronic Disease / Iron Deficiency Anemia - Chronic
inflammation suppresses erythropoiesis and reduces iron utilization.
○​ Severe Malnutrition / Cachexia - TB increases catabolic rate; low
appetite and chronic inflammation cause protein loss.
○​ Immune Suppression and Secondary Infections - Malnutrition +
chronic disease weaken immune defense.
D.​ Cardiovascular and Metabolic Complications
○​ Cor Pulmonale (Right-Sided Heart Failure) - Chronic hypoxia and
pulmonary fibrosis increase pulmonary arterial pressure → RV
hypertrophy and failure.
○​ Hepatotoxicity from Anti-TB Drugs - Isoniazid, Rifampicin, and
Pyrazinamide are hepatotoxic.
○​ Peripheral Neuropathy (from Isoniazid) - INH causes pyridoxine
deficiency.
○​ Optic Neuritis (from Ethambutol) - Dose-dependent toxicity to optic
nerve.
E.​ Pleural Complications
○​ Empyema (Infected Pleural Fluid) - Secondary bacterial infection of TB
effusion.
○​ Loculated Effusion / Non-resolving Effusion - Thick fibrinous
adhesions form within pleural space.

3.​ What additional tests would you request before finalizing your diagnosis?
Family history of lung cancer, we should continue to investigate for malignancy in
parallel, not instead of treatment.
A.​ Pleural Fluid
 ○​ Findings: High protein, LDH >200 IU/L, lymphocyte-predominant →
exudative, consistent with TB or malignancy.
○​ Additional Tests:
■​ GeneXpert MTB/RIF to confirm TB DNA and check for drug
resistance.
■​ Cytology to rule out malignant cells (adenocarcinoma can cause
similar effusion).
●​ If cytology negative but malignancy still suspected → plan
pleural biopsy (medical thoracoscopy or closed biopsy).
B.​ Sputum
○​ Findings: AFB-positive → Start TB treatment.
○​ Additional Tests:
■​ GeneXpert → pending (will determine rifampicin resistance →
may need MDR-TB regimen if positive).
■​ Sputum cytology → recommended, since the patient has
hemoptysis and family history of lung cancer (to detect malignant
cells).
C.​ Chest Imaging
○​ Findings: chest X-ray shows unilateral effusion with patchy opacity → TB
pleuritis likely.
○​ Additional Tests:
■​ Contrast-enhanced CT is essential to:
 ●​ Look for mass lesion, lymph node enlargement, cavitation,
or bronchial obstruction.
●​ If mass or nodal enlargement is seen → proceed to
bronchoscopy with biopsy or CT-guided biopsy.

4.​ How would you counsel the patient based on the current findings?
○​ Start with empathetic communication and explanation.
○​ Discuss the disease, transmission, and importance of treatment.
■​ Nature of the disease - TB is a bacterial lung infection that spreads
through the air when a person with TB coughs, sneezes, or speaks.
■​ Not hereditary - TB is not inherited; it’s an infection that can be cured.
■​ Treatment duration and possible side effects - TB treatment takes 6
months or longer, depending on the form and drug resistance. It’s
important to take medicines daily and consistently, even when symptoms
improve.
■​ Adherence - Missing doses can lead to drug resistance and relapse,
making the disease harder to cure.
■​ DOTS program - TB treatment is free under the National TB Control
Program (NTP) in the Philippines; enrolled under Directly Observed
Treatment, Short-course (DOTS) to ensure complete medication intake.
○​ Emphasize infection control and protection of family members.
■​ Infection prevention at home - Sleep in a well-ventilated area, cover
mouth/nose when coughing or sneezing, and wear a mask when around
others.
■​ Duration of infectiousness - After 2–4 weeks of continuous treatment,
less contagious.
■​ Household screening - All household members should undergo TB
screening (sputum exam or chest X-ray).
■​ Disposal of sputum - Cough into tissue or paper towel, dispose safely,
and wash hands regularly.
○​ Address nutrition and general health
■​ Explain that proper nutrition helps recovery:
1.​ High-protein diet (fish, eggs, beans, lean meat)
2.​ Energy-rich foods (rice, root crops)
3.​ Fresh fruits and vegetables for vitamins and minerals
■​ Encourage adequate hydration and rest.
 ■​ Avoid smoking and alcohol, as they worsen lung damage and delay
healing.
■​ Consider nutritional supplementation due to hypoalbuminemia and
BMI of 13 (severe malnutrition).
○​ Discuss emotional and psychosocial support
■​ Reassure the patient that TB is curable, and many patients recover
fully if they adhere to treatment.
■​ Address possible stigma — TB is common and should not be a source
of shame.
■​ Offer referral to counseling services or social workers for assistance
with financial or emotional burdens.
■​ If the patient fears cancer, explain that additional tests are ongoing
to confirm the diagnosis and that early detection leads to better
outcomes.
○​ Summarize follow-up and monitoring plan

Schedule Purpose

Monthly follow-up Monitor weight gain, symptom improvement, and

medication side effects.

2nd and 5th month sputum exams Check for conversion to negative AFB (treatment
response).

Baseline and periodic LFTs Monitor for drug-induced hepatotoxicity.

Nutritional reassessment Track BMI and albumin improvement.

LAJA​
Hematology

1.​ What type of anemia is suggested by the hemoglobin and hematocrit levels?
-​ The hemoglobin level of 9.8 g/dL indicates mild to moderate anemia, which may be
anemia of chronic disease secondary to chronic infection such as tuberculosis or an
underlying malignancy. In an immunocompromised patient, this type of anemia is
common due to persistent inflammation, cytokine-mediated suppression of
erythropoiesis, and altered iron metabolism. The normal WBC and platelet counts
suggest that bone marrow function is largely preserved, making marrow infiltration or
aplastic processes less likely at this stage.

2.​ How does the WBC differential reflect the patient's immune status?
-​ The total WBC count of 4.2 × 10⁹/L falls within the low-normal range, with a neutrophil
predominance (72%) and normal lymphocyte proportion (21%). This pattern may reflect
a stress or inflammatory response possibly from infection or malignancy. In an
immunocompromised patient, such as one with HIV or chemotherapy-induced
suppression, the absence of marked leukopenia suggests partial preservation of immune
competence, though functional immunity may still be impaired despite normal
quantitative counts.

3.​ Could the lymphocyte count be explained by a chronic infection or systemic illness?
-​ The normal lymphocyte proportion (21%) does not rule out chronic infection. In PTB,
relative lymphocytosis may sometimes occur, but in immunocompromised individuals,
especially those with HIV or malignancy, lymphocyte counts may remain normal or even
 decrease despite active disease. Thus, the lymphocyte count here may reflect a blunted
immune response secondary to immunosuppression, rather than absence of infection.

4.​ Are there any cytopenias that raise concern for marrow suppression or chronic
inflammation?
-​ Among the hematologic parameters, only the hemoglobin is reduced, while WBCs and
platelets remain normal. This indicates no generalized marrow failure, but the isolated
anemia could be due to chronic inflammation (from PTB or malignancy), anemia of
chronic disease, or nutritional deficiency common in debilitated or chronically ill patients.
Continuous monitoring is warranted, as progression of malignancy, infection, or
therapy-related effects (e.g., chemotherapy, anti-TB drugs) could later lead to marrow
suppression or pancytopenia.
TUBAT
Chemistry and Metabolic Markers
1.​ What could explain the elevated total protein with low albumin?
-​ Elevated total serum protein mainly comes from elevated globulin fractions
(especially γ-globulins). TB is a chronic inflammatory and infectious disease,
which stimulates immunoglobulin production as part of the immune response.
Hence, there’s hypergammaglobulinemia increased antibodies (IgG, IgA).
-​ Albumin is a negative acute-phase reactant its production by the liver decreases
during chronic infection and inflammation. Also, malnutrition, poor appetite, and
hepatic dysfunction in TB patients further reduce albumin synthesis. Sometimes,
protein loss (e.g., via nephrotic-range proteinuria or exudative effusions) can
worsen hypoalbuminemia.
2.​ How does hypoalbuminemia affect fluid dynamics, particularly in pleural effusion?
-​ Albumin plays a crucial role in maintaining plasma oncotic pressure, the “pulling
force” that keeps fluid within the vascular compartment. When serum albumin
levels decrease, as commonly seen in chronic infections like TB due to
inflammation, poor nutrition, or hepatic dysfunction, the plasma oncotic pressure
also drops. This reduction weakens the opposing force to capillary hydrostatic
pressure, allowing more fluid to leak out of blood vessels into interstitial spaces,
including the pleural cavity.
3.​ Is mild hyperglycemia clinically significant in this context?
-​ Yes, mild hyperglycemia can be clinically significant in a patient with tuberculosis
(TB), especially when accompanied by significant weight loss. Although transient
or mild elevation in blood glucose may seem minor, it has important diagnostic,
pathophysiologic, and prognostic implications in this context.
-​ Tuberculosis is a chronic infectious disease that triggers systemic inflammation
and stress responses, leading to increased secretion of counter-regulatory
hormones such as cortisol, catecholamines, and glucagon. These hormones
promote hepatic glucose production and insulin resistance, resulting in
stress-induced hyperglycemia. In malnourished or chronically ill TB patients, this
effect may be amplified despite their overall poor nutritional status. Thus, mild
 hyperglycemia may reflect an ongoing metabolic stress reaction to infection
rather than established diabetes.
4.​ Are there any signs of renal or hepatic dysfunction that would alter management?
-​ Both renal and hepatic function tests are within normal range. This makes a good
baseline for pharmacological management with the patient. The patient can be managed
with the usual management for Tuberculosis. However, low serum albumin in
tuberculosis is a red flag for poor nutritional and inflammatory status. It does not alter the
standard anti-TB drug regimen, but it should prompt active nutritional intervention, closer
monitoring for drug toxicity, and attention to overall patient recovery and immune
support.
5.​ Would you consider testing calcium, LDH, or Tumor markers? Why or why not?
-​ In a patient with confirmed tuberculosis, the presence of significant weight loss, a
family history of cancer, and occupational exposure from mining warrants broader
consideration beyond infection alone. While tuberculosis can fully explain many
constitutional symptoms, such as chronic cough and weight loss, the coexistence
of risk factors for malignancy justifies a more comprehensive evaluation. Testing
for serum calcium is reasonable because tuberculosis can cause hypercalcemia
through increased macrophage-mediated activation of vitamin D, while certain
cancers—particularly those involving bone or the lung—can produce similar
findings. Checking LDH levels may also be informative, as elevated LDH can
reflect tissue injury or inflammation; markedly high values, especially in pleural
effusion, may raise suspicion for malignant involvement. Tumor markers, on the
other hand, are not routinely indicated in TB but may be considered if imaging
reveals mass-like lesions, non-resolving infiltrates, or other atypical features
suggestive of coexisting cancer.
-​ Given the patient’s mining occupation, exposure to silica, radon, or asbestos
increases the risk for silicosis and lung malignancy, conditions that can overlap
with or predispose to tuberculosis. Therefore, performing a chest CT scan
alongside selective laboratory tests such as calcium and LDH is justified to
distinguish pure TB from a dual pathology involving cancer.
-​
ANG
Pleural Fluid Analysis
1. Is this effusion transudative or exudative? What supports your answer?
Classification: Exudative effusion
Supporting data: Pleural protein >3 g/dL and LDH 500 IU/L meet Light’s criteria
for exudate.
Likely etiologies: Tuberculosis, malignancy, or chronic inflammatory process (due
to lymphocyte predominance).

2. What does lymphocyte predominance suggest?

The lymphocyte predominance in the pleural fluid suggests a chronic
inflammatory process. In our setting, this pattern most strongly supports
 tuberculous pleural effusion, though other causes such as malignancy and
chylothorax remain in the differential. ADA testing and cytology will help
differentiate these etiologies.

3. How do the LDH and glucose levels guide your interpretation?

The elevated LDH confirms that this is an exudative pleural effusion, due to active
inflammation or tissue damage.

The normal glucose level argues against bacterial empyema or rheumatoid

effusion and is more consistent with tuberculous pleuritis or malignant effusion.

Together with the lymphocyte predominance, tuberculous pleural effusion is the

most likely cause.

4. Would you consider pleural biopsy or ADA testing at this point?

Given the lymphocytic, exudative nature of the effusion with normal glucose and
elevated LDH, our leading consideration is tuberculous pleural effusion. We
would proceed with pleural fluid ADA testing for biochemical support. Should the
ADA result be equivocal or if malignancy remains a strong differential, a pleural
biopsy for histologic and microbiologic confirmation will be warranted.

5. How does the ultrasound finding of an unloculated effusion guide your next steps?
The ultrasound finding of an unloculated effusion indicates that the pleural fluid is
free-flowing and not organized, allowing safe diagnostic thoracentesis and
favoring conservative management initially. This supports proceeding with ADA
testing and cytology rather than immediate drainage or surgical intervention.

ELOC
1.​ What could explain the anemia and low albumin in this patient?
●​ The anemia is most likely anemia of chronic disease (ACD) secondary to chronic
infection (tuberculosis).
●​ Mechanism: Chronic inflammation → ↑ hepcidin → impaired iron release and
erythropoiesis → normocytic or mildly microcytic anemia.
●​ Elevated ferritin (acute phase reactant) supports this.
●​ The low albumin reflects:
●​ Chronic inflammatory state (negative acute phase reactant),
●​ Poor nutritional intake (patient reports fatigue, anorexia, and weight loss),
●​ Possible protein loss from inflammation-related capillary leak or pleural effusion.​

2.​ Are there signs of immune dysregulation or chronic inflammation?

●​ Yes — multiple indicators:
●​ ESR 78 mm/hr, CRP 48 mg/L — strong evidence of chronic inflammation.
 ●​ Ferritin 420 ng/mL — elevated as an acute phase reactant.
●​ Low albumin, lymphocytic predominance in pleural fluid (70%) — suggests a
cell-mediated immune response typical of tuberculous pleuritis.
●​ Oral thrush and cachexia (BMI 13.0) may indicate immune dysregulation or underlying
immunocompromise (e.g., HIV).

3.​ Would you consider screening for other chronic infections or systemic conditions?
●​ Yes — strongly recommended.
●​ Since TB is diagnosed (positive sputum AFB, lymphocytic exudative effusion),
co-infections and comorbidities must be screened for:
●​ Recommended tests:
●​ HIV test (high priority) — oral thrush, cachexia, and anemia raise suspicion.
●​ Hepatitis B and C serology — endemic in the Philippines and may worsen malnutrition or
anemia.
●​ Stool exam (for helminthic infection or occult blood loss).
●​ Nutritional deficiencies (iron studies, B12, folate if available).​

4.​ Could this be a case of immune suppression or marrow infiltration?

●​ Immune suppression:
○​ Suggested by oral thrush, severe weight loss, and chronic infection → HIV is a
leading concern.
○​ Chronic TB can also cause secondary immunosuppression.
●​ Bone marrow infiltration:
○​ TB can rarely infiltrate bone marrow → pancytopenia, but this case shows normal
WBC and platelets, so marrow infiltration is less likely.
○​ Anemia is isolated — consistent with functional suppression (ACD), not infiltrative
marrow disease.

MEJORADA
1.​ What conditions endemic to our city and region match the clinical and diagnostic profile?
A.​ Pulmonary Tuberculosis (PTB)
●​ Highly endemic in Zamboanga Peninsula and throughout the Philippines.
●​ Risk factors:
○​ Crowded living conditions (urban apartment)
○​ Occupational exposure (mining, poor ventilation, dust)
○​ Malnutrition and low BMI
○​ Smoking history
●​ Clinical features in the case (cough >2 weeks, weight loss, pleuritic pain, blood-streaked
sputum, fatigue, lymphadenopathy, clubbing) are classic for TB.
B.​ HIV Infection (co-endemic with TB)
●​ TB is the most common opportunistic infection in people with HIV in this region.
●​ The presence of oral thrush and generalized hyperpigmented maculopapular rash could
suggest possible HIV co-infection.​
C.​ Chronic Obstructive Pulmonary Disease (COPD) secondary to smoking and dust
exposure
●​ May coexist or mimic some TB symptoms (chronic cough, dyspnea), though less likely in
this case given systemic findings.​

2.​ How does the patient's occupation and social context influence your diagnostic thinking?
●​ The patient works in mining with poor ventilation and dust exposure — a
significant risk for silicosis, which increases susceptibility to tuberculosis infection
and reactivation.
●​ The patient lives in a crowded apartment → facilitates airborne TB transmission.
●​ He is a smoker (5 pack-years) → impairs mucociliary clearance, increasing TB
risk.
●​ Low BMI and weight loss → possible chronic infection or malnutrition contributing
to lowered immunity.
●​ Anxiety about stigma → may delay seeking diagnosis or treatment, worsening
transmission risk.

3.​ What public health implications arise if your leading diagnosis is confirmed?
●​ If TB is confirmed, several public health implications arise:
●​ Transmission Risk: TB is airborne, and undiagnosed/untreated cases can infect multiple
people, especially in households, workplaces, and crowded urban areas.
●​ Occupational Hazard: Mining environments could lead to TB outbreaks among workers
due to poor ventilation and silica dust exposure.
●​ Potential HIV-TB Syndemic:
●​ The possibility of HIV co-infection has implications for integrated TB/HIV control
programs.
●​ Economic and Social Burden:
○​ Loss of productivity due to chronic illness.
○​ Financial strain from prolonged treatment.
○​ Stigma associated with TB leading to isolation or delayed care.
●​ Need for Strengthened TB Control Programs:
○​ Active case finding, treatment adherence support, and education to prevent
default.
4.​ What steps would you take to ensure proper contact tracing and containment?
●​ A structured TB control and containment plan would include:
A.​ Notification and Documentation
●​ Report the case to the local health office (Zamboanga City Health Department)
as TB is a notifiable disease.
●​ Register the patient in the National Tuberculosis Control Program (NTP).

B.​ Contact Tracing

●​ Identify household contacts (wife, two children) and occupational contacts
(coworkers in the mining site).
●​ Screen all close contacts using:
○​ Symptom screening (cough, fever, weight loss)
○​ Chest X-ray
○​ Sputum AFB smear / GeneXpert MTB/RIF
○​ TST or IGRA, especially for children or asymptomatic contacts.
C.​ Infection Control Measures
●​ Educate the patient on cough etiquette, mask use, and adequate ventilation at
home.
●​ Encourage temporary isolation until sputum smear conversion.
●​ Promote nutritional support and adherence to Directly Observed Therapy,
Short-course (DOTS).
D.​ Preventive Therapy
●​ For close contacts (especially children <5 years or immunocompromised):
○​ Isoniazid preventive therapy (IPT) after ruling out active TB.
E.​ Workplace Measures
●​ Assess and improve ventilation and dust control at the mining site.
●​ Conduct periodic TB screening for workers.